Related by context. Frequent words. (Click for all words.) 75 INCB# [001] 75 #ME# 75 refractory chronic lymphocytic 74 R sorafenib tablets 74 Factor VIIa 73 sodium Injection 73 forodesine 73 liposomal formulation 72 PEG SN# 72 anticancer compound 71 Pivotal Phase III 71 KNS # 71 Traficet EN 71 MKC# 71 MEK inhibitor 71 CCX# 71 Aliskiren 71 multi kinase inhibitor 71 Nexavar ® 71 Genasense R oblimersen 71 Vandetanib 70 proteasome inhibitor 70 Kuvan R 70 mTOR inhibitor 70 Entereg R 70 diabetic neuropathic pain 70 Icatibant 70 Bortezomib 70 Proxinium TM 70 tezampanel 70 SERMs 70 Voreloxin 70 Belimumab 70 CORT # 70 DDP# 70 Gemzar ® 70 Daclizumab 70 immunomodulating 70 BAY #-# 70 Drug Candidate 69 Dasatinib 69 ATL# [001] 69 ICA # 69 Initiate Phase 69 elotuzumab 69 rNAPc2 69 Cetrorelix 69 thymalfasin 69 Recombinant Human 69 targeting CD# 69 PSN# [002] 69 Guanilib 69 HCV protease inhibitor 69 non alcoholic steatohepatitis 69 ELND# 69 Aurora kinase 69 nicotinic alpha 7 69 Pivotal Phase 69 MGCD# [001] 69 deforolimus 69 otelixizumab 69 Naproxcinod 69 GVAX R 69 Ixempra 69 Pirfenidone 69 pertuzumab 69 Phase III Clinical Trial 69 6R BH4 69 Mipomersen 69 humanized anti 69 atacicept 68 Azedra 68 Rebif ® 68 humanized monoclonal antibody 68 MNTX 68 Fibrillex TM 68 QNEXA 68 Boceprevir 68 TYGACIL 68 Perifosine 68 ANYARA 68 PS# [001] 68 Phase 2b clinical trials 68 Shigamabs ® 68 Irinotecan 68 OXi# 68 luteinizing hormone releasing 68 HCV protease 68 Harbor BioSciences 68 Preclinical Data 68 Allovectin 7 R 68 vorinostat 68 Patient Enrollment 68 talactoferrin 68 ixabepilone 68 alvimopan 68 MAP# 68 FDA Accepts 68 MAXY G# 68 BZL# 68 partial agonist